Evaluation of Prostate Cancer Recurrence with MR Imaging and Prostate Imaging for Recurrence Reporting Scoring System

Radiol Clin North Am. 2024 Jan;62(1):135-159. doi: 10.1016/j.rcl.2023.06.013. Epub 2023 Aug 21.

Abstract

Detection of prostate cancer recurrence after whole-gland treatment with curative intent is critical to identify patients who may benefit from local salvage therapy. Among the different imaging modalities used in clinical practice, MR imaging is the most accurate in identifying local prostate cancer recurrence; indeed, it is an excellent technique for local recurrence detection superior to PET/CT, even at low PSA, but provides no information about extra-pelvic lymph nodes or bone metastasis. In 2021, a group of experts developed the Prostate Imaging for local Recurrence Reporting scoring system to standardize acquisition, interpretation, and reporting of prostate cancer recurrence.

Keywords: Magnetic resonance imaging; Prostate cancer; Prostate cancer recurrence; Prostate imaging for local recurrence reporting; Standardization; Structured reporting.

Publication types

  • Review

MeSH terms

  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Recurrence, Local / pathology
  • Positron Emission Tomography Computed Tomography* / methods
  • Prostate / pathology
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology
  • Recurrence

Substances

  • Prostate-Specific Antigen